| RS1340894696 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1340911940 |
KDM6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 2, Inborn genetic diseases |
| RS1340914824 |
CUX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1340921963 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1340926191 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS1340926346 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Perrault syndrome, Bifunctional peroxisomal enzyme deficiency |
| RS1340928778 |
F11
|
Health Risk |
Likely pathogenic |
Hereditary factor XI deficiency disease, Hereditary factor XI deficiency disease |
| RS1340929933 |
CUL7
|
Health Risk |
Likely pathogenic |
3-M syndrome, 3-M syndrome |
| RS1340940049 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1340940841 |
CC2D2A
|
Health Risk |
Pathogenic |
Meckel syndrome, type 6 |
| RS1340942427 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1340949974 |
JUP
|
Health Risk |
Likely pathogenic |
Naxos disease, Naxos disease |
| RS1340952961 |
COL10A1
|
Health Risk |
Likely pathogenic |
— |
| RS1340959180 |
BUB1B
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 1, Mosaic variegated aneuploidy syndrome 1 |
| RS1340981566 |
EP300
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1340982465 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS1340989734 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1341004065 |
NHS
|
Health Risk |
Pathogenic |
Nance-Horan syndrome, Nance-Horan syndrome |
| RS1341020147 |
NBEAL2
|
Health Risk |
Likely pathogenic |
Gray platelet syndrome, Gray platelet syndrome |
| RS1341025285 |
TRPV4
|
Health Risk |
Likely pathogenic |
Neuronopathy, distal hereditary motor |
| RS1341026212 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1341032857 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS1341033162 |
PIGQ
|
Health Risk |
Pathogenic |
Epilepsy, Epilepsy |
| RS1341038926 |
STAT1
|
Health Risk |
Likely pathogenic |
— |
| RS1341055534 |
TBK1
|
Health Risk |
Pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Encephalopathy |
| RS1341064149 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1341083602 |
FARS2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 14, Combined oxidative phosphorylation defect type 14 |
| RS1341121356 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1341134360 |
TPRN
|
Health Risk |
Likely pathogenic |
— |
| RS1341165259 |
CD3D
|
Health Risk |
Likely pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS1341172185 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1341186496 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1341205888 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1341219224 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1341227088 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS1341243329 |
SOX9
|
Health Risk |
Pathogenic/Likely pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS1341244760 |
TONSL
|
Health Risk |
Likely pathogenic |
Sponastrime dysplasia, Sponastrime dysplasia |
| RS1341249433 |
CYP17A1
|
Health Risk |
Pathogenic |
— |
| RS1341292125 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1341298773 |
CEP250
|
Health Risk |
Pathogenic |
Cone-rod dystrophy and hearing loss 2, Cone-rod dystrophy and hearing loss 2 |
| RS1341359606 |
ARSL
|
Health Risk |
Likely pathogenic |
— |
| RS1341371726 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1341387039 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS1341401004 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1341424851 |
PATL2
|
Health Risk |
Pathogenic |
Oocyte maturation defect 4, Oocyte maturation defect 4 |
| RS1341441238 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS1341457041 |
ATM
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |
| RS1341463104 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS1341473353 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1341484544 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1341485123 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperinsulinism, Maturity-onset diabetes of the young type 1 |
| RS1341498364 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS1341498392 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1341502906 |
SLC2A10
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Arterial tortuosity syndrome |
| RS1341511822 |
NUP93
|
Health Risk |
Likely pathogenic |
NUP93-related disorder, NUP93-related disorder |
| RS13415309 |
IHH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1341540567 |
BBS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS1341545186 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS1341550325 |
FOXH1
|
Health Risk |
Likely pathogenic |
Conotruncal defect, Conotruncal defect |
| RS1341552636 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS1341566934 |
SERPINF1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 6, Osteogenesis imperfecta type 6 |
| RS1341570153 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1341592819 |
GUCY2D
|
Health Risk |
Pathogenic/Likely pathogenic |
maculopathy, Leber congenital amaurosis 1 |
| RS1341598207 |
MAK
|
Health Risk |
Pathogenic |
— |
| RS1341613149 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Medulloblastoma, Familial dysautonomia |
| RS1341621315 |
APOA5
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1341633213 |
ACE
|
Health Risk |
Pathogenic |
Renal tubular dysgenesis of genetic origin, Renal tubular dysgenesis of genetic origin |
| RS1341636573 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1341647863 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS1341652994 |
CAD
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile epileptic dyskinetic encephalopathy, Infantile epileptic dyskinetic encephalopathy |
| RS1341659417 |
LDLR
|
Health Risk |
Pathogenic |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1341667 |
STOX1
|
Health Risk |
risk factor |
Preeclampsia/eclampsia 4, Preeclampsia/eclampsia 4 |
| RS1341687319 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1341689711 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1341709717 |
MOGS
|
Health Risk |
Pathogenic |
MOGS-congenital disorder of glycosylation, MOGS-congenital disorder of glycosylation |
| RS1341720994 |
PIGN
|
Health Risk |
Pathogenic |
Multiple congenital anomalies-hypotonia-seizures syndrome 1, Multiple congenital anomalies-hypotonia-seizures syndrome 1 |
| RS1341745986 |
PARN
|
Health Risk |
Pathogenic |
— |
| RS1341751250 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1341755128 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1341763493 |
MANBA
|
Health Risk |
Likely pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1341782266 |
CPS1
|
Health Risk |
Pathogenic |
Congenital hyperammonemia, type I |
| RS1341789008 |
COL5A1
|
Health Risk |
Likely pathogenic |
— |
| RS1341804179 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1341806090 |
LRP5
|
Health Risk |
Pathogenic |
— |
| RS1341857958 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 4 |
| RS1341872544 |
ADSL
|
Health Risk |
Likely pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1341890249 |
DST
|
Health Risk |
Likely pathogenic |
— |
| RS1341891692 |
MAD1L1
|
Health Risk |
Pathogenic |
Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition, Mosaic variegated aneuploidy syndrome 7 with inflammation and tumor predisposition |
| RS1341894581 |
ECEL1
|
Health Risk |
Pathogenic |
Distal arthrogryposis type 5D, Inborn genetic diseases |
| RS1341908127 |
MEN1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1341922880 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1341948399 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1341974048 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1341974678 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1341981506 |
CEL
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 8, Maturity-onset diabetes of the young type 8 |
| RS1341988492 |
TFRC
|
Health Risk |
Pathogenic |
TFRC-related combined immunodeficiency, TFRC-related combined immunodeficiency |
| RS1342009710 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1342011335 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1342038737 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS1342054043 |
MORC2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2Z, Developmental delay |